Join us in congratulating Dr. Shuo Xiao, recipient of the 2024 New Investigator Award presented by the Society for the Study of Reproduction. Supported by the Virendra B. Mahesh New Investigator Fund, this award recognizes an active, regular member of the society for outstanding research completed and published within 12 years after receiving a Ph.D. or other equivalent professional degree. The award ceremony was held July 17, 2024, in Dublin, Ireland.

Dr. Xiao is an associate professor at the Department of Pharmacology and Toxicology at Rutgers University School of Pharmacy. He earned his MBBS and MS degrees in Preventive Medicine from Peking University Health Science Center, followed by a PhD in Female Reproductive Biology and Toxicology from Dr. Xiaoqin Ye’s lab at the University of Georgia. He completed the Postdoctoral Training under the supervision of Dr. Teresa Woodruff at Northwestern University and focused on Ovarian Biology, Oncofertility, and organ-on-a-chip.

Currently, Dr. Xiao’s research is dedicated to advancing women’s reproductive health, including investigating ovarian disrupting effects and mechanisms of environmental contaminants and clinical drugs, developing non-hormonal female contraception, and engineering female reproduction-on-a-chip. These research projects are funded by NIH, DOD, NSF, and Bill & Melinda Gates Foundation. So far, he has published more than 60 peer-reviewed papers in high impact journals. Dr. Xiao has been a SSR member since 2009. He served on the SSR Award Committee (2019-2022) and as a SSR Trainee Affairs Mentor (2017-2019). He is a current member of SSR Virtual Committee (2022-present).